Hawkeye Announces Letter of Intent to Acquire Six15 Technologies

Hawkeye Systems, Inc. (OTCQB:HWKE) (“Hawkeye”), a technology holding company, is pleased to announce today it has signed a Letter of Intent (LOI) to acquire Six15 Technologies (“Six15”), a technology company that designs, develops, and manufactures head-up displays (HUDs) for enterprise and defense users.

Hawkeye is currently expediting the completion of due diligence to finalize a definitive Agreement (“Agreement”) to complete an all-stock purchase of 100% of the shares of Six15. The Agreement will effectuate a reverse reorganization of the two companies in conjunction with an proposed growth capital financing.

Corby Marshall, CEO of Hawkeye, stated, “We are pleased to reach the successful culmination of our M&A process with the announcement of a truly robust growth acquisition opportunity in Six15.

Combining world-class technology with accomplished industry leadership, the Six15 Agreement is expected to return the Company to its original tech mission and its focus on building sustainable long- term shareholder value.”

Rich Ryan, CEO of Six15, commented, “We view the anticipated Agreement and subsequent capital raise as the final element needed to catalyze the hyper-growth phase of our business plan. We further believe our evolving narrative will be well-suited to attract and build long-term investor interest as a public company.”

Hawkeye anticipates there will be a name and symbol change as part of the transaction. A reverse stock split is also being discussed.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”